30% trade margin cap approved for non-scheduled anti-cancer drugs

Indian Government has approved a cap on supply and sale margins for non-scheduled anti-cancer drugs. The measure is intended to reduce medicine prices and improve affordability. DGHS will finalise the medicines covered, following which NPPA will decide and issue the notification.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.